The latest Health Policy Brief from Health Affairs and the Robert Wood Johnson Foundation describes a new expedited drug development pathway designed to speed up the Food and Drug Administration’s (FDA’s) premarketing approval process for drugs and devices
Read More...
Read the complete post at http://healthaffairs.org/blog/2014/05/16/new-health-policy-brief-breakthrough-therapy-designation/?utm_source=rss&utm_medium=rss&utm_campaign=new-health-policy-brief-breakthrough-therapy-designation
Posted
May 16 2014, 06:30 AM
by
Health Affairs Blog